cellular
|
• reduced T cell proliferation
|
immune system
| N |
• mice exhibit normal thymic and splenic gamma-delta T17 cells
|
|
• spleen enlarged 3-5X by 10-15 weeks of age
|
|
• absent germinal centers in B cell follicles of spleen
|
|
• decreased membrane IgM
• increased membrane IgM
|
|
• late stage B cell maturation blocked
|
|
• proportion of dendritic cells in spleen 50% of controls but proportion as expected in thymus
• single (+) CD4 dendritic cells reduced to about 10% of control levels in the spleen
|
|
• no plasma cells in spleen or lamina propria
|
|
• normal lymphocyte distribution at 4-5 weeks of age
• expanded numbers of T and B lymphocytes at 10-15 weeks of age
|
|
• absent germinal centers in B cell follicles of lymph nodes
|
|
• enlarged 10X by 10-15 weeks of age
|
|
• reduced T cell proliferation
|
|
• all immunoglobulin classes reduced by 99% or more
|
|
• no cytotoxic T cell response to lymphocytic choriomeningitis virus
|
neoplasm
|
• unable to reject injected tumor cells
|
hematopoietic system
|
• reduced T cell proliferation
|
|
• decreased membrane IgM
• increased membrane IgM
|
|
• late stage B cell maturation blocked
|
|
• proportion of dendritic cells in spleen 50% of controls but proportion as expected in thymus
• single (+) CD4 dendritic cells reduced to about 10% of control levels in the spleen
|
|
• no plasma cells in spleen or lamina propria
|
|
• normal lymphocyte distribution at 4-5 weeks of age
• expanded numbers of T and B lymphocytes at 10-15 weeks of age
|
|
• spleen enlarged 3-5X by 10-15 weeks of age
|
|
• absent germinal centers in B cell follicles of spleen
|
|
• all immunoglobulin classes reduced by 99% or more
|
growth/size/body
|
• spleen enlarged 3-5X by 10-15 weeks of age
|


Analysis Tools